Respironics, Inc.
 

 
 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 4, 2005

RESPIRONICS, INC.

(Exact name of Registrant as specified in its charter)
         
Delaware
  000-16723   25-1304989
 
       
(State or Other Jurisdiction of
Incorporation)
  (Commission File
Number) 		  (I.R.S. Employer
Identification Number)
     
1010 Murry Ridge Lane
Murrysville, Pennsylvania
  15668-8525
 
   
(Address of Principal
Executive Offices)
  (Zip Code)

724-387-5200

(Registrant’s telephone number, including area code)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

TABLE OF CONTENTS

     
  Page
   
Item 2.02. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Item 7.01. REGULATION FD DISCLOSURE
SIGNATURES
INDEX TO EXHIBITS
   2
2
3
4

 

 

Item 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On April 4, 2005, Respironics, Inc. issued a press release announcing that it has acquired 100 percent of the outstanding shares of Mini-Mitter Company, Inc. In that press release, Respironics, Inc. also reported that there will be no change in financial outlook or guidance based on the acquisition . A copy of the press release is attached hereto as Exhibit 99.

Item 7.01. REGULATION FD DISCLOSURE.

     The information provided in Item 2.02 of this Current Report on Form 8-K is incorporated by reference.

Exhibits

      99        Press release, dated April 4, 2005, issued by Respironics, Inc.

2

 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    RESPIRONICS, INC.
  By:   /s/ Daniel J. Bevevino
       
      Daniel J. Bevevino
Vice President, and Chief Financial and
Principal Accounting Officer

Dated: April 4, 2005

3

 

INDEX TO EXHIBITS

       
Exhibit No.
  Description
 
   
99
  Press release, dated April 4, 2005, issued by
Respironics, Inc.

4